Перейти к содержанию

Bristol Myers Squibb Co (BMY) stock: revenue, earnings & dividend

Bristol Myers Squibb Co (BMY, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener BMY · NYSE Pharma & Biotech US-NJ

Key figures

Fiscal year
2025
Revenue
48.2 bn $
Revenue growth
-0.2 %
Revenue growth 5y (p.a.)
2.5 %
Net income
7.05 bn $
Net margin
14.6 %
Operating margin
–
Earnings per share (diluted)
3.46 $
Dividend per share
2.49 $
Payout ratio
72 %
Consecutive dividend years
17 years
Consecutive dividend raises
16 years
Dividend growth 5y (p.a.)
6.2 %
Total assets
90 bn $
Equity
18.5 bn $
Equity ratio
20.5 %
Return on equity
38.2 %
Cash
10.2 bn $
Operating cash flow
14.2 bn $
Free cash flow
12.8 bn $
Shares outstanding
2,044,085,831

History

Revenue by fiscal year

2016 19.4 bn $
2017 20.8 bn $
2018 22.6 bn $
2019 26.1 bn $
2020 42.5 bn $
2021 46.4 bn $
2022 46.2 bn $
2023 45 bn $
2024 48.3 bn $
2025 48.2 bn $

Net income by fiscal year

2016 4.46 bn $
2017 1.01 bn $
2018 4.92 bn $
2019 3.44 bn $
2020 -9.02 bn $
2021 6.99 bn $
2022 6.33 bn $
2023 8.03 bn $
2024 -8.95 bn $
2025 7.05 bn $

Dividend per share

2016 1.53 $
2017 1.57 $
2018 1.61 $
2019 1.68 $
2020 1.84 $
2021 2.01 $
2022 2.19 $
2023 2.31 $
2024 2.42 $
2025 2.49 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202548.2 bn $7.05 bn $3.46 $2.49 $14.2 bn $
202448.3 bn $-8.95 bn $-4.41 $2.42 $15.2 bn $
202345 bn $8.03 bn $3.86 $2.31 $13.9 bn $
202246.2 bn $6.33 bn $2.95 $2.19 $13.1 bn $
202146.4 bn $6.99 bn $3.12 $2.01 $16.2 bn $
202042.5 bn $-9.02 bn $-3.99 $1.84 $14.1 bn $
201926.1 bn $3.44 bn $2.01 $1.68 $8.21 bn $
201822.6 bn $4.92 bn $3.01 $1.61 $7.07 bn $
201720.8 bn $1.01 bn $0.61 $1.57 $5.28 bn $
201619.4 bn $4.46 bn $2.65 $1.53 $3.06 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)